Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells


The Company
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells.
Pipeline
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen® to identify novel compounds that target and kill CSCs.


News
&
Events
4/8/2014
Stemline Announces FDA Acceptance of IND for Glioma Brain Tumor Vaccine SL-701
4/7/2014
Stemline Therapeutics to Present at 13th Annual Needham Healthcare Conference
4/1/2014
Stemline to Present SL-501 Preclinical Efficacy in TKI-resistant CML at AACR
Copyright 2014 - Stemline Therapeutics, Inc. All rights reserved
Stemline